FDA Center for Drug Evaluation & Research Issues Warning Letter to GSC Products
May 27, 2026
May 27, 2026
WASHINGTON, May 27 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to GSC Products LLC from its Center for Drug Evaluation and Research:
* * *
Recipient: Wayne Perry, Founder and President, GSC Products, LLC, 1441 Van Patten Rd, Duanesburg, NY 12056-2522, United States, (b)(6), (b)(7)(C)
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETT . . .
* * *
Recipient: Wayne Perry, Founder and President, GSC Products, LLC, 1441 Van Patten Rd, Duanesburg, NY 12056-2522, United States, (b)(6), (b)(7)(C)
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETT . . .